The UK has left the EU on January 31, 2020, implicating substantial and unprecedented consequences for pharmaceutical and medical device companies exporting to, or from, the UK and for those with supply chains operating between the UK and the EU, including those shipping products to Northern Ireland from the rest of the UK.
The impact on the pharmaceutical and medical device industry is enormous, as it not only concerns UK companies that trade products or services with the EU or the U.S., but also has an effect on any EU business with activities on the UK market as well as on non-EU businesses, including U.S.-companies, using the UK as hub for their export to the EU.
Approaching the topic from the EU and UK perspectives, members of our Trade, EU Regulatory and M&A teams will discuss in this webinar:
- Driving forces in the UK negotiations with the EU
- EU regulatory issues
- Impact on transactions
If you have questions concerning this roundtable webinar, email email@example.com.
King & Spalding is an accredited provider of CLE credit in California, Georgia, Illinois, New York and Texas. We can issue reciprocal credit for attorneys licensed in Connecticut, Florida, and New Jersey. We will apply for credit in Colorado, North Carolina and Virginia (subject to MCLE Board approval). For jurisdictions not listed, attendees are provided with a Universal Certificate of Attendance. New York licensed attorneys: Transitional/Appropriate for newly-admitted and experienced attorneys. Financial aid is available for qualifying lawyers. For CLE-related questions, please contact Gisel Arias, firstname.lastname@example.org. King & Spalding, 1180 Peachtree Street NE, Atlanta, GA 30309. CA Provider #10947.
General information on our practice is available in our electronic publications Serving the Life Sciences Industry and Serving the Healthcare Industry. If you would like to be included on our regular pharmaceutical manufacturers, medical device manufacturers or healthcare provider mailing lists to receive notices of other events and written updates, you can be added by submitting your full contact information to email@example.com and specifying the list you wish to join.